What is the typical ALT (alanine aminotransferase) to LDH (lactate dehydrogenase) ratio in ischemic (shock‑type) hepatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ALT/LDH Ratio in Ischemic Hepatitis

In ischemic (shock-type) hepatitis, the ALT/LDH ratio is typically less than 1.5, with a mean ratio of approximately 0.87, which is markedly lower than the ratio seen in acute viral hepatitis (mean 4.65).

Diagnostic Utility of the Ratio

The ALT/LDH ratio serves as a valuable discriminator between different causes of acute hepatocellular injury 1. When evaluating patients with marked aminotransferase elevations (>5 times upper limit of normal), this ratio helps distinguish ischemic hepatitis from other etiologies:

  • Ischemic hepatitis: Mean ALT/LDH ratio = 0.87 1
  • Acute viral hepatitis: Mean ALT/LDH ratio = 4.65 1
  • Acetaminophen toxicity: Mean ALT/LDH ratio = 1.46 1

An ALT/LDH ratio cutoff of 1.5 differentiates acute viral hepatitis from ischemic hepatitis with 94% sensitivity and 84% specificity 1. This means ratios below 1.5 strongly suggest ischemic or toxic injury rather than viral hepatitis.

Characteristic Laboratory Pattern

In ischemic hepatitis, the disproportionately elevated LDH relative to ALT reflects the pathophysiology of hepatocellular hypoxia and necrosis. Typical findings include 2:

  • Markedly elevated LDH: Mean approximately 6,085 IU/L
  • Elevated ALT: Mean approximately 2,073 IU/L
  • Severe coagulopathy: Mean INR of 5.86
  • Transient renal dysfunction: Present in >90% of cases

Clinical Context

The magnitude of enzyme elevation alone does not determine clinical significance 3. Context is critical—ischemic hepatitis typically occurs in patients with:

  • Multiple comorbidities (>90% have ≥3 conditions) 2
  • Left heart failure (88%) 2
  • Right heart failure (68%) 2
  • Respiratory failure and hypoxemia (68%) 2
  • Episodes of hypotension (38%) 2

Important Caveats

The extent of liver enzyme abnormality does not necessarily correlate with prognosis 4, 3. In ischemic hepatitis specifically, mortality is high (41% at 3 months) but deaths result from the underlying cardiac/systemic disease rather than hepatic injury itself 2. The liver injury typically resolves spontaneously once hemodynamic stability is restored.

When interpreting any abnormal liver chemistry, the clinical scenario must guide evaluation rather than relying solely on algorithmic approaches 4. The ALT/LDH ratio should be used as one component of the diagnostic assessment alongside clinical presentation, hemodynamic status, and cardiac function.

Related Questions

A patient with hemoglobin 187 g/L, AST approximately 500 U/L, ALT approximately 90 U/L, total bilirubin 5.7 mg/dL (direct 3.9 mg/dL) – what is the appropriate next step in management?
What are the causes and management of significantly elevated Alanine Transaminase (ALT) and Aspartate Transaminase (AST) levels above 1000 in a patient?
What are the next steps for a patient with elevated Alanine Transaminase (ALT) and normal Aspartate Transaminase (AST) levels?
How should I evaluate and manage a patient with an alanine aminotransferase (ALT) level greater than ten times the upper limit of normal?
What is the management for a child presenting with abdominal distension, semiconsciousness, moderate hepatomegaly, elevated Serum Glutamic-Pyruvic Transaminase (SGPT) levels, and anemia, with a history of fever for 3 days?
What is the clinical significance and interpretation of the lactate dehydrogenase (LDH) to alanine aminotransferase (ALT, SGPT) ratio?
In a patient with methicillin‑resistant Staphylococcus aureus (MRSA) pneumonia who is already receiving daptomycin and meropenem, what is the appropriate antibiotic choice?
How should a neonate with a prenatal ultrasound showing a dilated renal pelvis be evaluated and managed?
Should I start amoxicillin‑clavulanate (Augmentin) for a patient with an upper respiratory tract infection who is not improving on azithromycin?
What are the GOLD classification stages and groups (A, B, C, D) for chronic obstructive pulmonary disease (COPD)?
Should I hold warfarin when my International Normalized Ratio is 3.9?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.